Big news for peptide therapy. The FDA just removed 12 peptides including BPC 157, GHK Cu, and Epitalon from the Category 2 restricted list, opening the door to formal scientific review The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Pptido de cobre GHK GHK Cu Tripptido 1 GHK Cu (Copper Peptide) Provider Supervised Therapy IV Glow Bar